Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,403,814 | 2,777,334 | 2,180,550 | 2,000,067 | 712,582 |
| Marketable Securities | 187,137 | 377,147 | 390,000 | 401,776 | 805,907 |
| Receivables | 3,231,662 | 3,595,674 | 3,028,050 | 3,520,890 | 3,419,300 |
| Inventories | 2,157,310 | 2,131,073 | 2,137,800 | 2,071,156 | 1,921,960 |
| Other current assets | 0 | 0 | 0 | 1 | 1 |
| TOTAL | $7,979,923 | $8,881,228 | $7,736,400 | $7,993,889 | $6,859,750 |
| Non-Current Assets | |||||
| PPE Net | 4,459,167 | 4,484,600 | 4,233,450 | 4,120,288 | 3,825,138 |
| Investments And Advances | 292,536 | 326,474 | 300,150 | 295,901 | 289,588 |
| Intangibles | 397,361 | 403,300 | 427,350 | 320,357 | 319,020 |
| Other Non-Current Assets | 381,157 | 398,693 | 403,650 | 677,626 | 888,732 |
| TOTAL | $5,530,221 | $5,613,068 | $5,364,600 | $5,414,172 | $5,322,478 |
| Total Assets | $13,510,140 | $14,494,290 | $13,101,000 | $13,408,060 | $12,182,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 87,904 | 34,029 | 68,400 | 61,671 | 60,047 |
| Accounts payable and accrued liabilities | 542,339 | 893,235 | 669,300 | 810,083 | 553,146 |
| Other current liabilities | 5,758,083 | 5,530,892 | 4,717,650 | 4,739,584 | 4,742,709 |
| TOTAL | $7,012,690 | $7,048,990 | $6,238,800 | $6,308,103 | $6,074,845 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 716,426 | 716,401 | 661,650 | 629,474 | 591,156 |
| TOTAL | $718,291 | $718,332 | $663,150 | $631,296 | $593,079 |
| Total Liabilities | $7,730,981 | $7,767,322 | $6,901,950 | $6,939,399 | $6,667,924 |
| Shareholders' Equity | |||||
| Common Shares | 73,134 | 75,786 | 76,500 | 77,469 | 76,908 |
| Retained earnings | 5,841,973 | 6,852,095 | 6,158,400 | 6,457,269 | 5,334,753 |
| Other shareholders' equity | -133,943 | -199,907 | -34,850 | -65,076 | 104,643 |
| TOTAL | $5,779,164 | $6,726,974 | $6,199,050 | $6,468,662 | $5,514,304 |
| Total Liabilities And Equity | $13,510,145 | $14,494,296 | $13,101,000 | $13,408,061 | $12,182,228 |